文献速递心律失常瓣膜病与结构性心脏病

心律失常性二尖瓣脱垂的表现与结局

Presentation and Outcome of Arrhythmic Mitral Valve Prolapse.
PubMed 文献 · J Am Coll Cardiol · 2020-01-01

该队列纳入595例二尖瓣脱垂(MVP)患者,通过24小时动态心电图和超声心动图评估室性心律失常及其与长期结局的关系。结果显示室性心律失常常见但重度少见,重度心律失常独立关联于二尖瓣环分离、瓣叶冗余和复极异常,且与显著超额死亡相关。

要点

  • MVP患者中43%存在至少≥5%的室性早搏,重度室性心动过速(≥180次/分)仅占9%。
  • 重度心律失常独立预测因素为二尖瓣环分离、瓣叶冗余和T波倒置/ST段压低。
  • 重度心律失常与8年死亡率增加独立相关(调整后HR 2.94,95%CI 1.36-6.36)。

核心结论

  • MVP患者中室性心律失常常见但重度少见,心律失常性MVP以二尖瓣环分离、瓣叶冗余和复极异常为特征,且重度心律失常独立关联超额死亡。

研究设计与样本

  • 连续纳入595例MVP患者(年龄65±16岁,278例女性),进行临床、24小时动态心电图和 Doppler 超声心动图评估,分析长期结局。

主要发现

  • 43%患者至少存在≥5%的室性早搏,27%为中度室速(120-179次/分),9%为重度室速(≥180次/分)。
  • 室性心律失常与男性、双叶脱垂、显著瓣叶冗余、二尖瓣环分离、左房增大、左室收缩末期内径增大及T波倒置/ST段压低相关(均p≤0.001)。
  • 重度心律失常独立关联于二尖瓣环分离、瓣叶冗余和T波倒置/ST段压低(均p<0.0001),但与二尖瓣反流严重程度或射血分数无关。
  • 8年总死亡率13±2%,随心律失常严重程度增加(无/轻微10±2%,轻/中度15±3%,重度24±7%;p=0.02)。
  • 重度心律失常与死亡率、除颤器植入、室速消融的复合终点独立相关(调整后HR 4.68,95%CI 2.45-8.92;p<0.0001),尤其在药物治疗下(调整后HR 5.80,95%CI 2.75-12.23;p<0.0001)。

临床怎么用

  • 对MVP患者应进行24小时动态心电图评估室性心律失常,尤其关注二尖瓣环分离、瓣叶冗余和复极异常等高危表型。
  • 重度室性心律失常患者需加强风险分层和随访,考虑个体化治疗策略,包括器械治疗或消融的评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Mitral valve prolapse (MVP) is often considered benign but recent suggestion of an arrhythmic MVP (AMVP) form remains incompletely defined and uncertain. OBJECTIVES: This study determined ventricular arrhythmia prevalence, severity, phenotypical context, and independent impact on outcome in patients with MVP. METHODS: A cohort of 595 (age 65 ± 16 years; 278 women) consecutive patients with MVP and comprehensive clinical, arrhythmia (24-h Holter monitoring) and Doppler-echocardiographic characterization, was identified. Long-term outcomes were analyzed. RESULTS: Ventricular arrhythmia was frequent (43% with at least ventricular ectopy ≥5%), most often moderate (ventricular tachycardia [VT]; 120 to 179 beats/min) in 27%, and rarely severe (VT ≥180 beats/min) in 9%. Presence of ventricular arrhythmia was associated with male sex, bileaflet prolapse, marked leaflet redundancy, mitral annulus disjunction (MAD), a larger left atrium and left ventricular end-systolic diameter, and T-wave inversion/ST-segment depression (all p ≤ 0.001). Severe ventricular arrhythmia was independently associated with presence of MAD, leaflet redundancy, and T-wave inversion/ST-segment depression (all p < 0.0001) but not with mitral regurgitation severity or ejection fraction. Overall mortality after arrhythmia diagnosis (8 years; 13 ± 2%) was strongly associated with arrhythmia severity (8 years; 10 ± 2% for no/trivial, 15 ± 3% for mild and/or moderate, and 24 ± 7% for severe arrhythmia; p = 0.02). Excess mortality was substantial for severe arrhythmia (univariate hazard ratio [HR]: 2.70; 95% confidence interval [CI]: 1.27 to 5.77; p = 0.01 vs. no/trivial arrhythmia), even after it was comprehensively adjusted, including for MVP characteristics (adjusted HR: 2.94; 95% CI: 1.36 to 6.36; p = 0.006) and by time-dependent analysis (adjusted HR: 3.25; 95% CI: 1.56 to 6.78; p = 0.002). Severe arrhythmia was also associated with higher rates of mortality, defibrillator implantation, VT ablation (adjusted HR: 4.68; 95% CI: 2.45 to 8.92; p < 0.0001), particularly under medical management (adjusted HR: 5.80; 95% CI: 2.75 to 12.23; p < 0.0001), and weakly post-mitral surgery (adjusted HR: 3.69; 95% CI: 0.93 to 14.74; p = 0.06). CONCLUSIONS: In this large cohort of patients with MVP, ventricular arrhythmia by Holter monitoring was frequent but rarely severe. AMVP was independently associated with phenotype dominated by MAD, marked leaflet redundancy, and repolarization abnormalities. Long-term severe arrhythmia was independently associated with notable excess mortality and reduced event-free survival, particularly under medical management. Therefore, AMVP is a clinical entity strongly associated with outcome and warrants careful risk assessment and well-designed clinical trials.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Essayagh B, Sabbag A, Antoine C, et al. Presentation and Outcome of Arrhythmic Mitral Valve Prolapse. J Am Coll Cardiol. 2020. PMID: 32762897. doi:10.1016/j.jacc.2020.06.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。